{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:26:54Z","timestamp":1794576414190,"version":"4.9.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT160100226"],"award-info":[{"award-number":["FT160100226"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.coph.2018.07.010","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T07:39:01Z","timestamp":1534923541000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite"],"prefix":"10.1016","volume":"42","author":[{"given":"Rowena E","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H","family":"Shafik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashika N","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.07.010_bib0005","series-title":"World Malaria Report 2017","author":"World Health Organisation Global Malaria Programme","year":"2017"},{"key":"10.1016\/j.coph.2018.07.010_sbref0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coph.2018.07.010_bib0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin\u2013piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.coph.2018.07.010_sbref0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12936-017-1845-5","article-title":"Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia","volume":"16","author":"Mukherjee","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.coph.2018.07.010_bib0030","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1128\/AAC.00920-16","article-title":"Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandan schoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity","volume":"60","author":"Nankabirwa","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/AAC.05454-11","article-title":"Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya","volume":"56","author":"Okombo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0040","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)","volume":"191","author":"Sisowath","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0045","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/596738","article-title":"In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa","volume":"199","author":"Sisowath","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coph.2018.07.010_bib0055","doi-asserted-by":"crossref","first-page":"e20212","DOI":"10.1371\/journal.pone.0020212","article-title":"Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance","volume":"6","author":"Veiga","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2018.07.010_sbref0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype\u2013genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0065","first-page":"275","article-title":"Hemoglobin degradation","volume":"295","author":"Goldberg","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coph.2018.07.010_sbref0070","first-page":"406","article-title":"Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins","volume":"129","author":"Xie","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.coph.2018.07.010_bib0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2958.2006.05368.x","article-title":"PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX","volume":"62","author":"Bray","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2018.07.010_bib0080","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","article-title":"Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs","volume":"74","author":"Fitch","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.coph.2018.07.010_bib0085","doi-asserted-by":"crossref","first-page":"e00303","DOI":"10.1128\/mBio.00303-17","article-title":"A variant PfCRT isoform can contribute to Plasmodium falciparum resistance to the first-line partner drug piperaquine","volume":"8","author":"Dhingra","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coph.2018.07.010_bib0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2018.07.010_bib0095","doi-asserted-by":"crossref","first-page":"e1005725","DOI":"10.1371\/journal.ppat.1005725","article-title":"Molecular mechanisms for drug hypersensitivity induced by the malaria parasite\u2019s chloroquine resistance transporter","volume":"12","author":"Richards","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2018.07.010_bib0100","doi-asserted-by":"crossref","first-page":"18883","DOI":"10.1073\/pnas.0911317106","article-title":"Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine","volume":"106","author":"Sa","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2018.07.010_bib0105","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/507115","article-title":"Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin","volume":"194","author":"Sidhu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_sbref0110","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2018.07.010_bib0115","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35002615","article-title":"Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum","volume":"403","author":"Reed","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.coph.2018.07.010_bib0120","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/molbev\/msh205","article-title":"The malaria parasite\u2019s chloroquine resistance transporter is a member of the drug\/metabolite transporter superfamily","volume":"21","author":"Martin","year":"2004","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.coph.2018.07.010_bib0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/345255a0","article-title":"Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum","volume":"345","author":"Foote","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.coph.2018.07.010_bib0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.coph.2018.07.010_bib0135","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1365-2958.2010.07272.x","article-title":"Efflux of a range of antimalarial drugs and `chloroquine resistance reversers\u2019 from the digestive vacuole in malaria parasites with mutant PfCRT","volume":"77","author":"Lehane","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2018.07.010_bib0140","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite\u2019s chloroquine resistance transporter","volume":"325","author":"Martin","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.coph.2018.07.010_bib0145","doi-asserted-by":"crossref","first-page":"e39569","DOI":"10.1371\/journal.pone.0039569","article-title":"Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesicles","volume":"7","author":"Papakrivos","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2018.07.010_bib0150","doi-asserted-by":"crossref","first-page":"E1759","DOI":"10.1073\/pnas.1322965111","article-title":"Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"111","author":"Summers","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2018.07.010_bib0155","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/infdis\/jiv509","article-title":"Verapamil-sensitive transport of quinacrine and methylene blue via the Plasmodium falciparum chloroquine resistance transporter reduces the parasite's susceptibility to these tricyclic drugs","volume":"213","author":"van Schalkwyk","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0160","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1002\/j.1460-2075.1992.tb05378.x","article-title":"Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum","volume":"11","author":"Barnes","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.coph.2018.07.010_bib0165","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1021\/bi7002026","article-title":"Heterologous expression and ATPase activity of mutant versus wild type PfMDR1 protein","volume":"46","author":"Amoah","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.coph.2018.07.010_bib0170","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2958.2008.06413.x","article-title":"Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum","volume":"70","author":"Sanchez","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2018.07.010_bib0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0166-6851(93)90048-3","article-title":"Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum","volume":"58","author":"Karcz","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.coph.2018.07.010_sbref0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cell.2017.06.030","article-title":"Functional profiling of a Plasmodium genome reveals an abundance of essential genes","volume":"170","author":"Bushell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coph.2018.07.010_bib0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/mmi.13373","article-title":"Vital and dispensable roles of Plasmodium multidrug resistance transporters during blood- and mosquito-stage development","volume":"101","author":"Rijpma","year":"2016","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2018.07.010_sbref0190","doi-asserted-by":"crossref","first-page":"eaap7847","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.coph.2018.07.010_bib0195","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00018-011-0906-0","article-title":"Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics","volume":"69","author":"Summers","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.coph.2018.07.010_bib0200","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/cb4008953","article-title":"Quinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P. falciparum","volume":"9","author":"Hrycyna","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coph.2018.07.010_bib0205","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","article-title":"Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine","volume":"91","author":"Cowman","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2018.07.010_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0169-4758(96)10003-X","article-title":"The ATP-binding cassette (ABC) gene family of Plasmodium falciparum","volume":"12","author":"Rubio","year":"1996","journal-title":"Parasitol Today"},{"key":"10.1016\/j.coph.2018.07.010_bib0215","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1074\/jbc.M806944200","article-title":"Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione","volume":"284","author":"Raj","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2018.07.010_bib0220","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1128\/AAC.03337-14","article-title":"Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response","volume":"58","author":"Veiga","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0225","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","article-title":"Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase","volume":"94","author":"Sirawaraporn","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2018.07.010_bib0230","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum","volume":"94","author":"Triglia","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2018.07.010_bib0235","doi-asserted-by":"crossref","first-page":"e1002132","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance","volume":"13","author":"Dogovski","year":"2015","journal-title":"PLoS Biol"},{"key":"10.1016\/j.coph.2018.07.010_sbref0240","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in Plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coph.2018.07.010_bib0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coph.2018.07.010_sbref0250","doi-asserted-by":"crossref","first-page":"e1006930","DOI":"10.1371\/journal.ppat.1006930","article-title":"Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites","volume":"14","author":"Rocamora","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2018.07.010_bib0255","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2017-11-814665","article-title":"Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance","volume":"131","author":"Bhattacharjee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.coph.2018.07.010_sbref0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12936-016-1095-y","article-title":"Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children","volume":"15","author":"Muwanguzi","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.coph.2018.07.010_sbref0265","doi-asserted-by":"crossref","first-page":"25379","DOI":"10.1038\/srep25379","article-title":"PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers","volume":"6","author":"Eastman","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2018.07.010_bib0270","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1021\/acs.langmuir.7b01132","article-title":"The effects of quinoline and non-quinoline inhibitors on the kinetics of lipid-mediated beta-hematin crystallization","volume":"33","author":"Fitzroy","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.coph.2018.07.010_bib0275","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1365-2958.2011.07855.x","article-title":"Genetic linkage analyses redefine the roles of PfCRT and PfMDR1 in drug accumulation and susceptibility in Plasmodium falciparum","volume":"82","author":"Sanchez","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2018.07.010_bib0280","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.coph.2018.07.010_bib0285","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/mmi.13035","article-title":"Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter","volume":"97","author":"Petersen","year":"2015","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2018.07.010_bib0290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12936-015-0642-2","article-title":"Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy","volume":"14","author":"Gadalla","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.coph.2018.07.010_bib0295","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/AAC.00119-06","article-title":"Targeting of hematin by the antimalarial pyronaridine","volume":"50","author":"Auparakkitanon","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13071-016-1358-z","article-title":"The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine","volume":"9","author":"Madamet","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.coph.2018.07.010_bib0305","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/AAC.47.4.1391-1394.2003","article-title":"In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon","volume":"47","author":"Basco","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0310","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01334-07","article-title":"Determinants of in vitro drug susceptibility testing of Plasmodium vivax","volume":"52","author":"Russell","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0315","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1128\/AAC.00183-10","article-title":"Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum","volume":"54","author":"Briolant","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0320","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1475-2875-12-431","article-title":"In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene","volume":"12","author":"Pascual","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.coph.2018.07.010_bib0325","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/infdis\/jiu141","article-title":"Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children","volume":"210","author":"Conrad","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0330","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/AAC.01656-08","article-title":"Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro","volume":"53","author":"Muangnoicharoen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_sbref0335","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II\u2013III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2018.07.010_sbref0340","doi-asserted-by":"crossref","first-page":"e02309","DOI":"10.1128\/AAC.02309-17","article-title":"Inactivation of plasmepsins 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine","volume":"62","author":"Mukherjee","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0345","doi-asserted-by":"crossref","first-page":"ofw229","DOI":"10.1093\/ofid\/ofw229","article-title":"Artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda","volume":"4","author":"Taylor","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0350","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/AAC.00939-10","article-title":"Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay","volume":"55","author":"Wong","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0355","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.03647-14","article-title":"In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine in Burkina Faso","volume":"59","author":"Baraka","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0360","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/AAC.01413-09","article-title":"Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether\u2013lumefantrine and amodiaquine\u2013sulfadoxine\u2013pyrimethamine but not dihydroartemisinin\u2013piperaquine in Burkina Faso","volume":"54","author":"Some","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0365","doi-asserted-by":"crossref","first-page":"54088","DOI":"10.1074\/jbc.M409605200","article-title":"Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy","volume":"279","author":"Omara-Opyene","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2018.07.010_bib0370","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1074\/jbc.M409740200","article-title":"The role of Plasmodium falciparum food vacuole plasmepsins","volume":"280","author":"Liu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2018.07.010_bib0375","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/AAC.00947-09","article-title":"Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum","volume":"54","author":"Chavchich","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0380","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2018.07.010_bib0385","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/503423","article-title":"Molecular and pharmacological determinants of the therapeutic response to artemether\u2013lumefantrine in multidrug-resistant Plasmodium falciparum malaria","volume":"42","author":"Price","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0390","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1128\/AAC.06350-11","article-title":"pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine","volume":"56","author":"Veiga","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0395","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/AAC.03265-14","article-title":"Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains","volume":"59","author":"Chugh","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/mol.61.1.35","article-title":"Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum","volume":"61","author":"Cooper","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2018.07.010_bib0405","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AAC.00638-09","article-title":"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1","volume":"53","author":"Mwai","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.07.010_bib0410","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/ng.528","article-title":"Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs","volume":"42","author":"Mu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2018.07.010_bib0415","doi-asserted-by":"crossref","first-page":"e1000887","DOI":"10.1371\/journal.ppat.1000887","article-title":"Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum","volume":"6","author":"Valderramos","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2018.07.010_bib0420","doi-asserted-by":"crossref","first-page":"11672","DOI":"10.1073\/pnas.1507142112","article-title":"Adaptive evolution of malaria parasites in French Guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt","volume":"112","author":"Pelleau","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2018.07.010_bib0425","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1126\/science.1205216","article-title":"Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets","volume":"333","author":"Yuan","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coph.2018.07.010_bib0430","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","article-title":"Directional selection at the pfmdr1, pfcrt, pfubp1 and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT","volume":"210","author":"Henriques","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2018.07.010_bib0435","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12936-016-1503-3","article-title":"Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether\u2013lumefantrine in Liberia","volume":"15","author":"Otienoburu","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.coph.2018.07.010_bib0440","doi-asserted-by":"crossref","first-page":"e0151565","DOI":"10.1371\/journal.pone.0151565","article-title":"Artesunate-amodiaquine and artemether\u2013lumefantrine therapies and selection of pfcrt and pfmdr1 alleles in Nanoro, Burkina Faso","volume":"11","author":"Sondo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2018.07.010_bib0445","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether\u2013lumefantrine and artesunate\u2013amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coph.2018.07.010_bib0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064299","article-title":"The role of PfMDR1 and PfCRT in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008\u20132011","volume":"8","author":"Eyase","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2018.07.010_bib0455","doi-asserted-by":"crossref","first-page":"e1000402","DOI":"10.1371\/journal.pmed.1000402","article-title":"A research agenda for malaria eradication: drugs","volume":"8","author":"The malERA Consultative Group on Drugs","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.coph.2018.07.010_bib0460","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/cb300454t","article-title":"Insights into the role of heme in the mechanism of action of antimalarials","volume":"8","author":"Combrinck","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coph.2018.07.010_bib0465","doi-asserted-by":"crossref","first-page":"e31623","DOI":"10.1371\/journal.pone.0031623","article-title":"Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure","volume":"7","author":"Mwai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2018.07.010_sbref0470","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1038\/nmicrobiol.2017.31","article-title":"Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis","volume":"2","author":"Wong","year":"2017","journal-title":"Nat Microbiol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:50:07Z","timestamp":1761461407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489218300444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":94,"alternative-id":["S1471489218300444"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.07.010","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}